期刊文献+

结外NK/T细胞淋巴瘤相关嗜血细胞综合征23例回顾性分析 被引量:11

23cases of extranodal NK/T-cell lymphoma associated with reactive haemophagocytic syndrome:A retrospective study
原文传递
导出
摘要 目的:探讨结外NK/T细胞淋巴瘤相关嗜血细胞综合征(natural killer/T-cell 1ymphoma associated hemophago-cytic syndrome,NK/T-LAHS)的临床特征、治疗效果和预后因素。方法:收集江苏大学附属昆山医院和复旦大学附属肿瘤医院2006-07-01-2011-09-30收治的NK/T细胞淋巴瘤患者146例,其中发生NK/T-LAHS者23例,回顾性分析其临床特征、实验室检查结果、治疗过程及预后情况。结果:23例NK/T-LAHs患者中位年龄45岁(21~79岁),男15例(65.2%)。19例(82.6%)原发部位为鼻及上呼吸道区域,另4例(17.4%)原发于结肠、宫颈和皮肤,P=0.035。所有患者治疗前血清LDH水平均〉250IU/L,高于正常,10例(43.5%)在继发HPS后LDH水平〉1000IU/L,较正常参考值升高〉4倍,P=0.018。NK/rr_LAHs临床表现多样,主要为发热、外周血细胞减少、肝功能异常和高甘油三酯血症,而骨髓中见到嗜血现象的仅有9例(39.1%)。中位生存期为8.5个月,中位NK/T-LAHS生存时间仅为14d。化疗和大剂量激素冲击效果不佳,死亡率达到100%。结论:NK/T-LAHS临床表现复杂,临床诊断较困难;病情发展快,有些患者在确诊后短时间内死亡,死亡原因多为多脏器衰竭、出血或感染。原发部位及血清LDH水平变化可能是NK/T-LAHS预后不良的主要因素。目前尚缺乏有效治疗手段。 OBJECTIVE: To investigate the clinical features,treatment effect and prognosis of extranodal NK/T-cell lymphoma associated hemophagocytic syndrome (NK/T- LAHS). METHODS: Totally 146 NK/T cell lymphoma patients diagnosed between July 2006 and September 2011 in Kunshan First People's Hospital and Affiliated Hospital of Fudan U niversity were included, of which 23 developed NK/T-LAHS. The information of clinical features, laboratory findings, treatments and prognosis of these patients were collected. RESULTS: Of the 23 NK/T- LAHS patients, the median age was 45 years old and 15(65.2%) were male. Nineteen(82.6%) cases originated from nasal cavity,nasal sinuses,and ton sil,while the other 4 (17. 4%/{) cases originated from colon, cervix, or skin (P = 0. 035). LDH levels were elevated 250 IU/L in all 23 cases at the time of diagnosis, and 10(43. 5%) cases showed elevated LDH levels of more than 1 000 IU/L at the onset of HPS,which predicted a poor prognosis(P=0. 018). NK/T-LAHS was characterized by fever, pancytopenia, liver disfunction, and hypertriglyceridemia, but only 9 cases (39.1%) were found hemophagocytosis in bone marrow. The median overall survival was 8.5 months,and the median LAHS survival time was 14 days. Chemotherapy and highdose glucocorticoids were not so effect to NK/T-LAHS that almost 100 % cases died soon. CONCLUSIONS: The clinical charac ters of NK/T-LAHS are complex,so the rate of its definite diagnosis at the early stage is low. Some cases even died in a short time after the diagnosis. Most of the patients died of multiorgan failure, infection and bleeding. The original lesion and LDH level may be prognostic factors. There is no effect treatment for NK/T-LAHS and it remains a challenge.
作者 张燕 洪小南
出处 《中华肿瘤防治杂志》 CAS 北大核心 2013年第21期1672-1675,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 NK T细胞 淋巴瘤 嗜血细胞综合征 预后 NK/T cell lymphoma hemophagocytic syndrome prognosis
  • 相关文献

参考文献14

  • 1Risdall RJ, McKenna RW, Nesbit ME, et al. Virus-associated he- mophagocytic syndrome a benign histiocytic proliferation distinct from malignant histioeytosis[J]. Cancer, 1979,44(3) : 993-1002.
  • 2Blom A, Beylot-Barry M, D' Incan M, et al. Lymphoma-associated hemophagocytic syndrome (LAHS) in advanced-stage mycosis fungoides/Szary syndrome cutaneous T-cell lymphoma [J]. J Am Acad Dermatol,2011,65(2) :404-410.
  • 3Choi YL, Park J H, Kim WS, et al. Aggressive NK-cell leukaemia associated with reactive haemophagocytie syndrome[J]. Clin Exp Dermatol,2006,31 (1) :83-85.
  • 4王晶石,王昭,吴林,田莉萍,陈晳.淋巴瘤相关性噬血细胞综合征14例临床分析[J].中国实验血液学杂志,2009,17(5):1352-1355. 被引量:28
  • 5Swerdlow SH,Campo E, Harris NL. World Health Organisation classification of tumours of haematopoietic and lymphoid tissues [M]. Lyon:IARC,2008.
  • 6Henter JI, Horne A, Arico M, et al. HLH-2004 Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [J]. Pediatr Blood Cancer, 2007,48(2) : 124-131.
  • 7Liapis K, Apostolidis J, Delimpasis S. EBV-associated hemoph- agocytic syndrome [J]. Am J Hematol,2011,86(5) :422.
  • 8Chuang HC, Lay JD, Hsieh WC, et al. Pathogenesis and mecha- nism of disease progression from hemophagocytic lymphohistio- cytosis to Epstein-Barr virus-associated T-cell lymphoma nuclear factor-kappa B pathway as a potential therapeutic target [J]. Cancer Sci,2007,98(9), 1281-1287.
  • 9Gupta A, Tyrrell P, Valani R, et al. The role of the initial bone marrow aspirate in the diagnosis o{ hemophagocytic lymphohisti- ocytosis[J]. Pediatr Blood Cancer, 2008,51 (3) : 402-404.
  • 10Takai K,Nikkuni K,Sanada M,et al. EB virus-associated periph- eral T cell lymphoma presenting with hemophagocytic syndrome and hepatic cell necrosis [J]. Rinsho Ketsueki, 2003,44 (7) 462- 467.

二级参考文献7

  • 1Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr, 2007; 166:95 - 109.
  • 2Han AR,Lee HR,Park BB, et al. Lymphoma-associated hemophagocytic syndrome:clinical features and treatment outcome. Ann Hematol, 2007 ; 86 : 493 - 498.
  • 3Henter JI, Home A, Arico M, et al. HLH-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistioeytosis. Pediatr Blood Cancer, 2007 ; 48 : 124 - 131.
  • 4Bielekova B, Catalfamo M, Reichert-Scrivner S, et al. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy ( daclizumab ) in multiple sclerosis. Proc Natl Acad Sci USA, 2006; 103:5941 -5946.
  • 5Kontopoulou T, Tsaousis G, Vaidakis E, et al. Hemophagocytic syndrome in association with visceral leishmaniasis. Am J Med, 2002; 113 : 439 - 440.
  • 6Gupta A, Tyrrell P, Valani R, et al. The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphobistiocytosis. Pediatr Blood Cancer, 2008; 51:402-404.
  • 7王昭,王旖旎,冯翠翠,田莉萍,陈皙.NK细胞活性与血清可溶性CD25水平检测在继发性噬血细胞性淋巴组织细胞增多症诊断中的意义[J].中国实验血液学杂志,2008,16(5):1154-1157. 被引量:44

共引文献27

同被引文献92

  • 1周立强,孙燕,谭文勇,李陶,王琦路,冯凤仪,王金万,储大同,石远凯,李晔雄,孙云田,吕宁.非霍奇金淋巴瘤1125例临床病理分析[J].癌症进展,2006,4(5):391-397. 被引量:47
  • 2Janka GE. Familial and acquired hemophagocyticlymphohistiocytosis[J]. Annu Rev Med,2012,63 :233 -246.
  • 3Takahashi N,Chubachi A,Kume M,et al. A clinical analysis of 52adult patients with hemophagocytic syndrome .. the prognostic signifi-cance of the underlying diseasesf J]. Int J Hematol,2001,74(2):209 -213.
  • 4Han AK, Lee HR,Park BB,et al. Lymphoma-associated hemoph-agocytic syndrome : clinical features and treatment outcome f J ].Ann Hematol, 2007,86 (7) :493 -498.
  • 5Sabattini E, Bacci F, Sagramoso C, et al. WHO classification oftumours of haematopoietic and lymphoid tissues in 2008: an over-view [J]. Pathologica,2010,102(3) :83 -87.
  • 6Sano H,Kobayashi R,Tanaka J,et al. Risk factor analysis of non-Hodgkin lymphoma-associated haemophagocytic syndromes : a mul-ticentre studyf J]. Br J Haematol,2014,165(6) :786 -792.
  • 7Tong H,Ren Y,Liu H,et al. Clinical characteristics of T-cell lym-phoma associated with hemophagocytic syndrome : comparison of T-cell lymphoma with and without hemophagocytic syndrome [ J ].Leuk Lymphoma ,2008,49 (1) :81 -87.
  • 8Takai K,Nikkuni K,Sanada M,et al. EB virus-associated peripher-al T cell lymphoma presenting with hemophagocytic syndrome andhepatic cell necrosis [ J ]. Rinsho Ketsueki,2003, 44 ( 7 ):.
  • 9Han L,Li L,Wu J,et al. Clinical features and treatment of naturalkiller/T cell lymphoma associated with hemophagocytic syndrome :comparison with other Tcell lymphoma associated with hemophago-cytic syndrome[ J]. LeukLymphoma, 2014,55(9) :2048 -2055.
  • 10Henter JI,Home A,Arico M,et al. HLH-2004 : Diagnostic and ther-apeutic guidelines for hemophagocyticlymphohistiocytosis[ J]. Pedi-atr Blood Cancer,2007,48(2) : 124 -131.

引证文献11

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部